Ahrens Investment Partners’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$13.4K Buy
+430
New +$13.1K 0.01% 557
2022
Q3
Sell
-430
Closed -$13K 259
2022
Q2
$13K Hold
430
0.01% 583
2022
Q1
$16K Hold
430
0.01% 616
2021
Q4
$17K Buy
+430
New +$15.9K 0.01% 605
2019
Q1
Sell
-18,170
Closed -$316K 175
2018
Q4
$316K Sell
18,170
-15,300
-46% -$308K 0.15% 106
2018
Q3
$826K Buy
+33,470
New +$825K 0.31% 66

Other funds holding BOUT

Ahrens Investment Partners's BOUT Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in CapForce IBD Breakout Opportunities ETF (BOUT) in Q1 2023: 430 shares worth $13.4K. The stake represents 0.01% of the portfolio and ranks #557 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in BOUT as recently as Q2 2022.

Ahrens Investment Partners first reported a position in BOUT in Q3 2018 and has held it in 6 quarters since. The position peaked at $826K in Q3 2018. 9 funds tracked by Wall St. Rank hold BOUT as of Q1 2023.

  • Ahrens Investment Partners held 430 shares of CapForce IBD Breakout Opportunities ETF worth $13.4K as of Q1 2023.
  • CapForce IBD Breakout Opportunities ETF was a new Ahrens Investment Partners position in Q1 2023.
  • CapForce IBD Breakout Opportunities ETF made up 0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #557 holding.
  • Ahrens Investment Partners first reported a position in CapForce IBD Breakout Opportunities ETF in Q3 2018 and has held it in 6 quarters since.
  • Ahrens Investment Partners's CapForce IBD Breakout Opportunities ETF position peaked at $826K in Q3 2018.
  • 9 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.